Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection Kampf S, Sponder M, Fabian Fitschek F, Laxar D, Bodingbauer M, Strobel O, Binder C, Stremitzer S, Kaczirek K, Schwarz C. Hepatobil Surg Nutr. 2023 Oct 1;12(5):704-714.
Diaphragmatic perforation as a result of cystic echinococcosis in an HIV positive migrant Schwarz C, Schmidbauer V, Lagler H, Stremitzer S, Kaczirek K, Langenberger H, Chromy D, Auer H, Gschwantler M. J Travel Med. 2023 Oct 31;30(6):taad108.
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy Primavesi F., Maglione M., Cipriani F., Denecke T., Oberkofler CE., Starlinger P., Dasari BVM., Heil J., Sgarbura O., Søreide K., Diaz-Nieto R., Fondevila C., Frampton AE., Geisel D., Henninger B., Hessheimer AJ., Lesurtel M., Mole D., Öllinger R., Olthof P., Reiberger T., Schnitzbauer AA., Schwarz Ch., Sparrelid E., Stockmann M., Truant S., Aldrighetti L., Braunwarth E., D'Hondt M., DeOliveira ML., Erdmann J., Fuks D., Gruenberger T., Kaczirek K., Malik H., Öfner D., Rahbari NN., Göbel G., Siriwardena AK., Stättner S. Br J Surg. 2023 Sep 6;110(10):1331-1347. doi: 10.1093
Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic Echinococcosis Hotz JF, Kaczirek K, Stremitzer S, Waneck F, Auer H, Perkmann T, Kussmann M, Bauer PK, Chen RY, Kriz R, Burgmann H, Ramharter M, Lagler H. Pathogens. 2022 Feb 18;11(2):261.
Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite stable colorectal liver metastases Stift J, Graf A, Neudert B, Herac M, Woeran K, Tamandl D, Laengle J, Schwarz C, Wrba F, Kaczirek K, Stremitzer S HPB (Oxford). 2021 June 7.
Prognosis and circumferential margin in patients with hilar cholangiocarcinoma Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Ann Surg Oncol. 2021 Mar;28(3):1493-1498.
Metachronous hepatic resection for liver only pancreatic metastases Schwarz C, Fitschek F, Primavesi F, Stättner S, Margonis GA, Weiss MA, Stavrou GA, Oldhafer KJ, Kornprat P, Wundsam H, Fischer I, Längle F, Függer R, Hauer A, Klug R, Kieler M, Prager G, Schindl M, Stremitzer S, Bodingbauer M, Sahora K, Kaczirek K. Surg Oncol. 2020 Aug 21;35:169-173.
Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz HJ, Scherer SJ. Br J Cancer. 2020 May;122(10):1518-1524.
Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz HJ, Scherer SJ. Br J Cancer. 2020 May;122(10):1518-1524.
Physical recovery after laparoscopic vs. open liver resection – a prospective cohort study Kampf S, Sponder M, Bergler-Klein J, Sandurkov C, Fitschek F, Bodingbauer M, Stremitzer S, Kaczirek K, Schwarz C. Int J Surg. 2019 Nov 14. pii: S1743-9191(19)30308-5.
The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlböck M, Kampf S, Asenbaum U, Starlinger P, Stremitzer S, Bodingbauer M, Kaczirek K. Sci Rep. 2019 Jun 10;9(1):8421.
Defining enhanced recovery after resection of peri-hilar cholangiocarcinoma. Quinn LM, Mann K, Jones RP, Bathla S, Stremitzer S, Dunne DF, Lacasia C, Fenwick SW, Malik HZ. Eur J Surg Oncol. 2019 Aug;45(8):1439-1445.
Clinical outcome after resection of early-stage hilar cholangiocarcinoma Stremitzer S, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ Eur J Surg Oncol. 2019 Feb;45(2):213-217.
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis Bhangu JS, Beer A, Mittlböck M, Tamandl D, Pulverer W, Schönthaler S, Taghizadeh H, Stremitzer S, Kaczirek K, Gruenberger T, Gnant M, Bergmann M, Mannhalter C, Weinhäusel A, Oehler R, Bachleitner-Hofmann T. Ann Surg. 2018 Nov;268(5):894-902.
DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells Laengle J, Stift J, Bilecz A, Wolf B, Beer A, Hegedus B, Stremitzer S, Starlinger P, Tamandl D, Pils D, Bergmann M. Theranostics. 2018 May 10;8(12):3198-3213.
Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases Stift J, Graf A, Schwarz C, Tamandl D, Starlinger P, Herac M, Beer A, Wrba F, Bodingbauer M, Kaczirek K, Stremitzer S. Eur J Surg Oncol. 2018 Jan;44(1):139-147.
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients Matsusaka S, Wu AH, Cao S, Hanna DL, Chin K, Yang D, Zhang W, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Stremitzer S, Yamauchi S, Okazaki S, Berger MD, Parekh A, Miyamoto Y, Mizunama N, Lenz HJ. Pharmacogenomics J. 2018 Apr;18(2):262-269.